Drop is a personalised digital health company.
Chronic inflammation plays a central role in health and disease. We measure inflammation, over time, using finger-prick blood taken at home to empower people to understand changes in their health
Our journey started with maternal health and diabetes…
Based in Australia and launching in 2020, we are taking advantage of a new understanding of blood biology and its predictive power relating to chronic inflammation and disease risk.
OUR CHRONIC INFLAMMATION FOCUS
Most people have experienced acute (short-term) inflammation, such as a cut or infection, which resolves relatively quickly. However, chronic, or long-term inflammation, has been identified as a major health risk and when unresolved can be harmful to human health.
There is strong evidence that chronic inflammation may be present and go undetected for months or years and is a key risk factor in the development of lifestyle diseases. In fact, two billion people are overweight or obese and over 20 million people die each year from related diseases including diabetes, heart failure and cancer.
Drop Bio is working to deliver personalised, longitudinal and actionable health information to help millions of people and their families understand and actively manage chronic inflammation risk.
|
|
|
|
|
1-10 employees
View all Drop Bio Health employees
|
|
|
Biotechnology
|
|
|
Sydney,New,AU
|
|
|
2018
|
|
|
Biotechnology, Biology, Mental Health, Digital Health, Wellbeing, Womens Health
|
Jim Liddle is the CEO of Drop Bio Health. To contact Jim Liddle email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.